Navigation Links
Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib
Date:3/30/2009

- Afinitor more than doubled time without tumor growth and reduced the risk of disease progression or death by 67% compared with placebo

- Only once-daily oral cancer treatment to directly target mTOR, a protein inside the cell that controls tumor cell division and blood vessel growth

- Phase III trials underway to explore potential of Afinitor in multiple additional cancers

EAST HANOVER, N.J., March 30 /PRNewswire/ -- Novartis announced today that Afinitor(R) (everolimus) tablets has been approved by the US Food and Drug Administration (FDA) for patients with advanced renal cell carcinoma (RCC) after failure of treatment with Sutent(R) (sunitinib)* or Nexavar(R) (sorafenib)**.

To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/novartis/36142

Prior to Afinitor, no other therapy has been studied in a Phase III trial in this patient population where there is an important unmet medical need(1). Sutent and Nexavar are commonly used as initial treatments for advanced RCC(2).

The approval is based on data that showed Afinitor, when compared with placebo, more than doubled the time without tumor growth or death in patients with advanced kidney cancer (4.9 vs. 1.9 months) and reduced the risk of disease progression or death by 67% (hazard ratio=0.33 with 95% confidence interval 0.25 to 0.43; P<0.0001)(3). Furthermore, additional data show that after 10 months of treatment with Afinitor, approximately 25% of patients still had no tumor growth(1) ***.

"This approval provides a new and useful tool for treating advanced renal cell cancer, representing an important step forward in managing this disease," said Robert J. Motzer, MD, attending physician, Memorial Sloan-Kettering Cancer Center, New York and principal investigator of the RECORD-1 trial, the bas
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Video: New Research Discovers Independent Brain Networks Control Human Walking
2. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
3. Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies
4. Video: Actress and New Mom Keri Russell Joins PKIDs to Launch Silence the Sounds of Pertussis Campaign
5. Video: Quest Diagnostics Health Trends(TM) Report Shows Significant Gap in Care for Patients With Chronic Kidney Disease
6. Video: New Results From One of the Worlds Largest Breast Cancer Trials Herald Hope for Thousands of Women
7. VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy
8. Video: The Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics Heart Health Test
9. Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer
10. Video: Clinical Study Shows Liraglutide Reduced Blood Sugar, Weight, and Blood Pressure in Patients with Type 2 Diabetes
11. Video: Sanford Healths Journey to Cure Type 1 Diabetes Receives Major Boost
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... , August 28, 2015 The scientific ... collaboration with one of the leading academics in the field ... world record holder in life extension for model animals - ... biology of aging and age-related diseases, primarily, around the stability ... has just been published as "Stability analysis of a model ...
(Date:8/28/2015)... DUBLIN , Aug. 28, 2015 Perrigo ... commented on the Mylan N.V. ("Mylan") (NASDAQ: MYL ... acquire Perrigo. "Our views of Mylan,s offer ... to be, based on our Board,s careful reflection of ... depend on the limited choices that Mylan has allowed ...
(Date:8/28/2015)... Denmark and ATLANTA ... 31, 2015 the US Food and Drug Administration (FDA) cleared ... Depressive Disorder in adult patients who have failed to receive ... TMS is a non-invasive technique for stimulating neural tissue in ... Major Depressive Disorder. The procedure has been proven safe and ...
Breaking Medicine Technology:Gero: Physics Meets Biology to Help Defeat Aging 2Gero: Physics Meets Biology to Help Defeat Aging 3Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 3Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 4Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 5Therapy System for Treating Major Depressive Disorder Receives FDA Clearance 2Therapy System for Treating Major Depressive Disorder Receives FDA Clearance 3
(Date:8/30/2015)... , ... August 31, 2015 , ... Avid collector Andrew ... the Doors Shrine Auditorium concert posters. This hand colored artwork is one of the ... in Los Angles. Hawley states, "When the doors played the Shrine, the band ...
(Date:8/30/2015)... ... August 31, 2015 , ... ... third of tax receipts, issues that are critically important to them are often ... attorneys and lobbyists monitoring proposed legislation and changing tax and regulatory policies. Smaller ...
(Date:8/30/2015)... ... August 31, 2015 , ... Intellitec ... Annual Convention & Expo October 5th & 6th in San Antonio, TX. Dedicated ... convention brings industry professionals from all over the country come to share the ...
(Date:8/30/2015)... ... August 31, 2015 , ... This month, top ... to help assisted living facilities and nursing homes protect their residents from neglect ... to security experts at the company, security systems don’t just protect; they also ...
(Date:8/30/2015)... ... August 30, 2015 , ... AvePoint, the established ... a Silver Sponsor of the Digital Workplace Conference, taking place Sunday, August 30 ... Throughout the event, AvePoint will showcase its file analysis, management, and migration solutions ...
Breaking Medicine News(10 mins):Health News:Newport Board Group, an Advisory Firm Serving the Middle Market, Issues Five Tips on Selling Services to the Government 2Health News:Newport Board Group, an Advisory Firm Serving the Middle Market, Issues Five Tips on Selling Services to the Government 3Health News:Newport Board Group, an Advisory Firm Serving the Middle Market, Issues Five Tips on Selling Services to the Government 4Health News:Intellitec Solutions to feature Microsoft Dynamics GP at AHCA/NCAL 66th Annual Convention & Expo 2Health News:Total Security Announces Security Systems Tips for New York Assisted Living Facilities and Nursing Homes 2Health News:Total Security Announces Security Systems Tips for New York Assisted Living Facilities and Nursing Homes 3Health News:AvePoint Showcases the Future of Enterprise Collaboration as Silver Sponsor of the Digital Workplace Conference in New Zealand 2Health News:AvePoint Showcases the Future of Enterprise Collaboration as Silver Sponsor of the Digital Workplace Conference in New Zealand 3Health News:AvePoint Showcases the Future of Enterprise Collaboration as Silver Sponsor of the Digital Workplace Conference in New Zealand 4
... Oct. 17 Health and,disability insurance companies are systematically ... of practices by health and disability,insurers and their effect ... Insurers provide no healthcare goods or services. ... inflation.,Medical debt is the number one cause of personal ...
... ANGELES, Oct. 17 The California Science,Center,s Science Matters ... in a free program from 1 - 3:30 p.m. ... the current science of,fear, which fears are innate and ... how our collective anxieties are shaped by culture and ...
... Home Workers From Across the Nation Rally for,Improved Nursing ... caravan from Toledo, Ohio to,Washington, DC to highlight concerns ... Wash., DC rally set for Oct 22, TOLEDO, ... caregivers from across the nation, senior advocates and,elected leaders ...
... 17 Lornamead, Inc., a leading,provider of personal ... branding professionals to its growing operation. Patti,D,Agostino joins ... Karen,Murabito joins as Marketing Director, Skin Care. This ... appointments over the past four months,reflecting the firm,s ...
... PHOENIX, Oct. 17, 2007 Two Arizona-based philanthropic ... innovative initiative to develop personalized molecular diagnostics. The ... every persons unique physiological makeup is critical to ... the same time reducing medical costs. , ...
... This is just another example of the Bush Administration promoting, politics ... with, the oversight of the federal family planning program ... ... Oct. 17 The National Abortion,Federation (NAF) denounces the appointment of ...
Cached Medicine News:Health News:Practices in Health & Disability Insurance - The Lives & Wealth They Cost America 2Health News:Manor Care Shareholders Vote to Approve $6.3 Billion Carlyle Buyout 2Health News:Lornamead Grows With Addition of Two Branding Pros 2Health News:The Virginia G. Piper Charitable Trust and Flinn Foundation launch 2Health News:The Virginia G. Piper Charitable Trust and Flinn Foundation launch 3Health News:The Virginia G. Piper Charitable Trust and Flinn Foundation launch 4Health News:National Abortion Federation Denounces the Appointment of Dr. Orr to Oversee Federal Family Planning Funds 2
... Pipette is a synonym for pipetting accuracy, ... design, and superior operating comfort. Its single, ... measuring stroke and blow-out as well as ... ensures utmost accuracy and precision. Ejection sleeve ...
... The new Finnpipette Focus from ... to combine ergonomics with uncompromising ... handle plate offers a custom ... The new shorter tip cones ...
... Pipette is a synonym for pipetting accuracy, ... design, and superior operating comfort. Its single, ... measuring stroke and blow-out as well as ... ensures utmost accuracy and precision. Ejection sleeve ...
... microprocessor controlled, Blanketrol II total ... provides effective patient warming and/or ... The Blanketrol II offers the ... rates of any hyper-hypothermia system ...
Medicine Products: